Literature DB >> 3012632

Peripheral low-density area of hepatic tumors: CT-pathologic correlation.

Y Muramatsu, K Takayasu, N Moriyama, Y Shima, H Goto, K Ushio, T Yamada, H Hasegawa, Y Koyama, S Hirohashi.   

Abstract

To aid in the distinction between colorectal cancer metastasis to the liver and hepatocellular carcinoma, findings on computed tomographic (CT) scans taken more than 5 minutes after contrast material administration ("late-enhanced CT scans") and pathologic findings were compared. Late-enhanced CT scans of metastatic adenocarcinoma showed a peripheral low-density area (PLDA) that corresponded to viable tumor and a central high-density area that represented fibrous connective tissue. This phenomenon was recognized in 15 of 20 (75%) patients with metastatic adenocarcinoma and in one of 50 (2%) patients with hepatocellular carcinoma. Late-enhanced CT scans may be useful in distinguishing between metastatic nonmucinous colorectal cancer and hepatocellular carcinoma.

Entities:  

Mesh:

Year:  1986        PMID: 3012632     DOI: 10.1148/radiology.160.1.3012632

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Capsule and mosaic pattern of hepatocellular carcinoma: correlation between CT and MR imaging.

Authors:  L Lalonde; B Van Beers; J Jamart; J Pringot
Journal:  Gastrointest Radiol       Date:  1992

2.  Progressive CT appearance of hepatic metastases from colorectal carcinoma.

Authors:  J G Letourneau; W M Thompson; M E Goldberg; D C Snover; T B Grage; M P Frick
Journal:  Gastrointest Radiol       Date:  1988

3.  Delayed enhancement of peripheral zone of neurofibromas at magnetic resonance imaging.

Authors:  Y Kurosaki; K Kuramoto; Y Itai
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

4.  Encapsulated hepatocellular carcinoma: radiologic findings and pathologic correlation.

Authors:  P R Ros; B J Murphy; J L Buck; G Olmedilla; Z Goodman
Journal:  Gastrointest Radiol       Date:  1990

5.  Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.

Authors:  Yun Shin Chun; Jean-Nicolas Vauthey; Piyaporn Boonsirikamchai; Dipen M Maru; Scott Kopetz; Martin Palavecino; Steven A Curley; Eddie K Abdalla; Harmeet Kaur; Chusilp Charnsangavej; Evelyne M Loyer
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

6.  Significance of angiogenic factors in liver metastatic tumors originating from colorectal cancers.

Authors:  A Nanashima; M Ito; I Sekine; S Naito; H Yamaguchi; T Nakagoe; H Ayabe
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

7.  Small (< or = 2 cm) atypical hepatic haemangiomas in the non-cirrhotic patient: pattern-based classification scheme for enhancement at triple-phase helical CT.

Authors:  M Scialpi; L Volterrani; M A Mazzei; S Cappabianca; F Barberini; I Piscioli; L Brunese; L Lupattelli
Journal:  Radiol Med       Date:  2009-07-04       Impact factor: 3.469

8.  Colorectal carcinoma evaluated by incremental dynamic CT: comparison of CT density, histology, and tumor size.

Authors:  H Furukawa; T Hara; T Taniguchi
Journal:  Gastroenterol Jpn       Date:  1992-06

9.  MR imaging of mixed hepatocellular and cholangiocellular carcinoma.

Authors:  T Hashimoto; H Nakamura; S Hori; K Tomoda; T Mitani; T Murakami; T Kozuka; M Monden; K Wakasa; M Sakurai
Journal:  Abdom Imaging       Date:  1994 Sep-Oct

Review 10.  Hypointense hepatic lesions depicted on gadobenate dimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: differentiation between benignancy and malignancy.

Authors:  Hye Sun Hwang; Seong Hyun Kim; Tae Yeon Jeon; Dongil Choi; Won Jae Lee; Hyo K Lim
Journal:  Korean J Radiol       Date:  2009-04-22       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.